Conditions:  Platinum-Resistant Fallopian Tube Carcinoma;  Platinum-Resistant Ovarian Carcinoma;  Platinum-Resistant Primary Peritoneal Carcinoma;  Recurrent Ovarian Carcinoma;  Stage IV Fallopian Tube Cancer AJCC v8;  Stage IV Ovarian Cancer AJCC v8;  Stage IV Primary Peritoneal Cancer AJCC v8
Interventions:  Procedure: Biopsy;  Drug: Pegylated SN-38 Conjugate PLX038
Sponsors:  Mayo Clinic;  National Cancer Institute (NCI)
**RECRUITING NOW**
Interventions:  Procedure: Biopsy;  Drug: Pegylated SN-38 Conjugate PLX038
Sponsors:  Mayo Clinic;  National Cancer Institute (NCI)
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
